Mitochondrial complex I activity in microglia sustains neuroinflammation

Luca Peruzzotti‐Jametti(University of Cambridge), Carolyn M. Willis(University of Cambridge), Grzegorz Krzak(University of Cambridge), Regan Hamel(University of Cambridge), Liviu Pirvan(Wellcome/MRC Cambridge Stem Cell Institute), Rosana-Bristena Ionescu(University of Cambridge), Julie A. Reisz(University of Colorado Denver), Hiran A. Prag(University of Cambridge), Monica Emili Garcia‐Segura(University of Cambridge), Vin‐Cent Wu(Imperial College London), Yaping Xiang(Imperial College London), B. Barlas(University of Cambridge), Alva M. Casey(University of Cambridge), Aletta M.R. van den Bosch(University of Cambridge), Alexandra M. Nicaise(University of Cambridge), L. Roth(University of Cambridge), G. R. Bates(University of Cambridge), Hailiang Huang(Imperial College London), Pranathi Prasad(University of Cambridge), Annelet Vincent(Wellcome Centre for Mitochondrial Research), Christian Frezza(University Hospital Cologne), Carlo Viscomi(University of Padua), Gabriel Balmus(University of Cambridge), Zoltán Takáts(Imperial College London), John C. Marioni(European Bioinformatics Institute), Angelo D’Alessandro(University of Colorado Denver), Michael P. Murphy(University of Cambridge), Irina Mohorianu(Wellcome/MRC Cambridge Stem Cell Institute), Stefano Pluchino(University of Cambridge)
Nature
March 13, 2024
Cited by 196Open Access
Full Text

Abstract

Abstract Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis 1 . Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells 2 . However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system 3 .


Related Papers

No related papers found

Powered by citation graph analysis